Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma

Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma

Background Systemic chemotherapy or chemoradiation therapy has proven to be effective in treating advanced biliary tract carcinoma (BTC). However, its efficacy in the adjuvant setting remains controversial. Therefore, this study aimed to determine the prognostic significance of genomic biomarkers in...

Full description

Bibliographic Details
Main Authors: Yunfeng Li, Chaochao Tan, Xinmin Yin, Siwei Zhu, Rongyao Cai, Chunhong Liao, Yifei Wu, Qihong Zeng, Chengzhi Cai, Wang Xie, Xiangyu He, Hao‐quan Wen, Guomin Lin, Qingqing He, Tingting He, Peng Gu, Chang‐jun Liu
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Cancer Medicine
Subjects:
adjuvant therapy
bile duct cancer
cholangiocarcinoma
gallbladder cancer
next‐generation sequencing
Online Access:https://doi.org/10.1002/cam4.6261

Internet

https://doi.org/10.1002/cam4.6261

Similar Items